The Size of the North America Coagulation/Hemostasis Analyzer Market is valued at USD 1.26 billion in 2022 and expected to grow at a CAGR of 9.76%, to reach USD 2.01 billion by 2027 during the forecast period 2022 to 2027.
Coagulation testing uses a set of methods for checking the hemostasis systems. Hemostasis is the process in which bleeding is prevented from a blood vessel. The instrument used in analyzing the coagulation system in a medical laboratory is called a Coagulometer. Almost all of the methods used in the laboratories today were developed more than fifty years ago.
All the methods for testing coagulation systems are broadly divided into two types, global tests, and local tests. Global tests produce results for the whole clotting cascade. Examples of global tests include the Thrombin generation test, Thromboelastography, and Thrombodynamics test. They play a key role in the first phase of diagnostics by producing in-depth analysis of the coagulation system. Local tests produce the results of different components of the blood coagulation cascade. Examples include Partial Thromboplastin time and the Prothrombin time test.
The driving factors of North America Coagulation/Hemostasis Analyzer market are increasing geriatric population, a growing number of people suffering from chronic blood disorders, growing incidence of chronic diseases, poor lifestyle choices, and an increase of foreign investments among others. The enormous expansion of hospitals and healthcare centers is also pushing the growth of this market in developing nations of Asia-Pacific.
This research report on the North America Coagulation/Hemostasis Analyzer Market has been segmented and sub-segmented into the following categories
By End User:
On the basis of test, prothrombin time testing has the largest market share in this segment and is also the fastest-growing due to increasing automation of this process in laboratories.
On the basis of product, Clinical laboratory analyzers have the largest market in this segment.
On the basis of end-user, Clinical laboratories have the largest share in the segment.
On the basis of technology, the Optical segment has the largest market share and is also the fastest-growing in this segment.
On the basis of region, the United States has the largest market share in the region owing to factors like the rising incidence of cardio metabolic disorders such as pulmonary embolism and deep vein thrombosis. It is also expected to be fastest growing in the region. Canada holds the second-largest share.
Promising Companies leading the North America Coagulation/Hemostasis Analyzer Market Profiled in the Report are Siemens AG (Germany), Thermo Fisher Scientific Inc. (U.S.), Roche Diagnostics (Switzerland), Alere Inc. (U.S.), Sysmex Corporation (Japan), Helena Laboratories (U.S.), Instrumentation Laboratory (U.S.), International Technidyne Corporation (U.S.), Nihon Kohden Corporation (Japan) and Diagnostica Stago (France).
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com